product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
Chloride Intracellular Channel 1
catalog :
CPTC-CLIC1-1
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CPTC-CLIC1-1
reactivity :
human
application :
western blot, ELISA, immunohistochemistry
more info or order :
product information
Internal ID :
5698
Name :
CPTC-CLIC1-1
Depositor Name :
Clinical Proteomics Technologies for Cancer
Depositor Institution :
National Cancer Institute
Depositor Website :
http://proteomics.cancer.gov
Date Deposited :
3/3/09
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
Chloride Intracellular Channel 1
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG2a
Isotype for catalog (legacy) :
IgG2a, kappa light chain
Positive Tested Species Reactivity :
Human
Depositor Notes (Special Instructions) :
This antibody has been validated by the Human Protein Atlas. http://www.proteinatlas.org/ENSG000
00213719?CLIC1/antibody.
Collections :
Cancer targets - NCI,Human
Search Keywords :
CLIC1; G6; NCC27; OTTHUMP00000029131; OTTHUMP00000029133; OTTHUMP00000029137; OTTHUMP00000174486; hRNCC; p64CLCP
Antigen Molecular Weight :
27.2 kDa
Gene :
CLIC1
Alternate Gene Name(s) :
CLIC1; G6; NCC27; hRNCC; p64CLCP
Uniprot ID :
O00299
Antibody Registry ID :
AB_1553432
Immunogen :
Recombinant Full Length Protein
Clonality :
Monoclonal
Myeloma Strain :
P3x63Ag8.653
Epitope Mapped :
No
Recommended Applications :
ELISA,FFPE,Immunohistochemistry,Microarray,Western Blot
Immunoblotting (legacy) :
yes
Western Blot Pubmed IDs :
24361864
Additional Information :
This antibody has been characterized only by ELISA or western blot. RRID:AB_1553432
Additional Characterization :
https://antibodies.cancer.gov/detail/CPTC-CLIC1-1
Human Protein Atlas :
http://www.proteinatlas.org/ENSG00000213719/antibody
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
questions and comments